The study on the diagnostic value of f/tPSA to the prostate cancer with tPSA greater than 10 ng/mL

来源 :泌尿生殖肿瘤华夏医学论坛2016暨长城国际泌尿男科转化医学论坛2016 | 被引量 : 0次 | 上传用户:wongbo
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Background: To investigate the differential value of the percentage of free to total prostate specific antigen (f/tPSA) in the diagnosis of prostate cancer (PCa) and benign prostatic hyperplasia (BPH) when the tPSA greater than or equal to 10 ng/mL.
其他文献
目的:评估终末期糖尿病肾病患者的糖代谢特点及腹膜透析(PD)对糖代谢的影响。方法:选取我院终末期糖尿病肾病拟行肾脏替代治疗的患者19例,使用动态血糖监测系统分别监测患者PD治疗前及PD治疗后24小时血糖,计算日间与夜间平均血糖、标准差、最高血糖、最低血糖、平均血糖波动幅度(MAGE)、最大血糖波动幅度(LAGE)、高血糖及低血糖的构成比,测定每组患者的糖化血红蛋白(HbA1c)、空腹及餐后2小时C
会议
研究目的:肾脏替代治疗(RRT)的起始时机与终止时机目前尚无定论,不恰当的开始或结束均会增加患者的并发症、住院时间和费用,甚至可能影响预后。心肾综合征的RRT治疗常兼顾肾功能和心功能,起始时机和终止时机可能与其他人群不同。本研究观察心肾综合征患者行RRT起始时机与终止时机。
Introduction: There are more than 2,000,000 dialysis patients all over the world.These patients experience high mortality and morbidity and poor health-related quality of life.Vascular access is calle
Introduction: Small ulcers decrease the quality of life significantly in patients with diabeticfoot syndrome.The major element in the causation of ulceration is a disturbance of venous blood flow and
Background: To assess the long-term follow-up outcomes of a novel diagnostic and therapeutic procedure for persistent or recurrent hemospermia by transurethral seminal vesiculoscopy.
Background: Renal cell carcinoma (RCC) is resistant to regular chemotherapy and radiation.Sunitinib,which targeted to VEGF receptor and other signal pathways,has been proved effective for prolonged ca
Background: Urothelial carcinoma of the bladder is a major cause of morbidity and mortality worldwide.Although localized bladder carcinomas could be managed by surgical resection,the recurrence and pr
Background: To evaluate the security and effect of brachytherapy for localized prostate cancer.Methods: Forty five patients with T1-T2 prostate cancer were treated with real-time transperineal ultraso
Background: To compare the efficacy and safety of transurethral PlasmaKinetic enucleation of prostate (PKEP) versus transurethral PlasmaKinetic resection of prostate (PKRP) for benign prostate hyperpl